Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05236062
What this trial is testing

Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial

Who this might be right for
Graft Vs Host DiseaseAcute-graft-versus-host DiseaseChronic Graft-versus-host-disease
Dana-Farber Cancer Institute 36
Testing effectiveness (Phase 2)Looking for participantsNCT06909110
What this trial is testing

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus Infections
Jessie L. Alexander 25
Not applicableLooking for participantsNCT04014374
What this trial is testing

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

Who this might be right for
Leukemia/LymphomaCutaneous T Cell LymphomaATLL
Kyowa Kirin, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT03856216
What this trial is testing

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaB Acute Lymphoblastic LeukemiaLymphocytic Neoplasm+1 more
M.D. Anderson Cancer Center 15
Large-scale testing (Phase 3)Study completedNCT00891384
What this trial is testing

Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 194
Large-scale testing (Phase 3)Study completedNCT00016068
What this trial is testing

Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation

Who this might be right for
Infection
Fred Hutchinson Cancer Center 184
Not applicableNo Longer AvailableNCT03172455
What this trial is testing

Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Acute-graft-versus-host DiseaseSteroid Refractory Acute Graft Versus Host DiseaseGraft-versus-host-disease+5 more
Impatients N.V. trading as myTomorrows
Early research (Phase 1)Looking for participantsNCT07025538
What this trial is testing

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Hematopoietic and Lymphatic System Neoplasm
City of Hope Medical Center 42
Early research (Phase 1)Study completedNCT02135406
What this trial is testing

CART-19 for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 13
Early research (Phase 1)Study completedNCT01254578
What this trial is testing

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT03286530
What this trial is testing

Ruxolitinib + Allogeneic Stem Cell Transplantation in AML

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia in RemissionAllogeneic Stem Cell Transplantation
Massachusetts General Hospital 64
Testing effectiveness (Phase 2)Study completedNCT01904136
What this trial is testing

Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Gene Mutations+6 more
M.D. Anderson Cancer Center 54
Large-scale testing (Phase 3)Active Not RecruitingNCT05515029
What this trial is testing

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis

Who this might be right for
Acute Lymphoblastic LeukemiaMyeloblastic LeukemiaBiphenotypic Acute Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 56
Post-approval studies (Phase 4)Looking for participantsNCT06339775
What this trial is testing

Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation

Who this might be right for
Acute B-cell Lymphoblastic Leukemia
Suping ZHANG 60
Testing effectiveness (Phase 2)Study completedNCT00460629
What this trial is testing

Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation

Who this might be right for
Chronic Myeloid Leukemia
University Hospital Carl Gustav Carus 20
Testing effectiveness (Phase 2)Study completedNCT00068718
What this trial is testing

Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant

Who this might be right for
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid Leukemia+3 more
Fred Hutchinson Cancer Center 35
Not applicableLooking for participantsNCT06211166
What this trial is testing

Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction

Who this might be right for
Acute LeukemiaMDSMDS/MPN+1 more
Peking University People's Hospital 300
Very early researchLooking for participantsNCT03665675
What this trial is testing

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCytomegalovirusDonor+2 more
Sumithira Vasu 20
Testing effectiveness (Phase 2)UnknownNCT03771222
What this trial is testing

Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies

Who this might be right for
Donor Lymphocyte InfusionPeripheral Blood Stem Cell TransplantationRelapse+2 more
Chinese PLA General Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01252017
What this trial is testing

Nilotinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Patients Who Have Received Allo-HSCT
National Taiwan University Hospital 36
Next Page